Back to Sites

Harare Family Care CRS

Site Number

31890

Address

Cnr Josiah Tongogara/Mazowe Street
Parirenyatwa Annex
Harare,
Zimbabwe

IMPAACT Members at this Site

David Mburuzabudu CAB Member

Audry Tasaranarwo CAB Member

Reginald Maonedzo CAB Representative

Zvenyika Alfred Gomo Co-Investigator

Francis Jaji Co-Investigator

Mavis Kahwemba Co-Investigator

Suzen Maonera Co-Investigator

Hilda Mujuru Co-Investigator

Richard Musana Co-Investigator

Mercy Mutambanengwe Co-Investigator

Rachel Mahachi CRS Coordinator

Sukunena Maturure CRS Coordinator

Mutsawashe Bwakura-Dangarembizi CRS Leader

James Hakim CRS Leader

Gift Chareka CTU Coordinator

Zvavahera Chirenje CTU Principal Investigator

Bola Adedeji DAIDS PO

Rufaro Katsande Data Manager

Tichaona Vhembo Investigator

Marshall Munjoma Laboratory Manager/Supervisor

Bangani Kusakara Medical Officer

Tapiwa Mbengeranwa Medical Officer

Tsungai Mhembere Pharmacist of Record

Studies at this Site

P1060: NNRTI-Based vs. PI-Based ART in Infants Exposed/Not Exposed to NVP for PMTCT

DAIDS Number

10166

Research Area

Treatment

Study Status

Concluded

P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects

DAIDS Number

10633

Research Area

Treatment

Study Status

Concluded

P1072: Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (RotaTeq™) in HIV-1 Infected and Uninfected Children Born to HIV-1 Infected Mothers

DAIDS Number

10638

Research Area

Complications & Comorbidities

Study Status

Concluded

P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age

DAIDS Number

10655

Research Area

Other

Study Status

Concluded

P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants

DAIDS Number

10732

Research Area

Tuberculosis

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Therapeutics

Study Status

Closed to Follow Up

P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children

DAIDS Number

11689

Research Area

Therapeutics

Study Status

Concluded

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Therapeutics

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls

DAIDS Number

11878

Research Area

Brain and Mental Health

Study Status

Participants Off Study and Primary Analysis Completed